Nonetheless, the molecular mechanisms underlying the tumor cell behavior and poor prognosis observed in patients with IGC tumors expressing high levels of THY1 have not yet been clarified, with few studies addressing this issue [36]. The gene discussed is THY1; the disease is neoplasm.